Related Experiment Videos
Chemical and serological properties of Mycoplasma hyorhinis fractions
Infection and Immunity
|June 1, 1973
Abstract:
Mycoplasma hyorhinis organisms were fractionated into lipid, carbohydrate, and protein fractions by chemical and physiochemical procedures. When all fractions were tested for complement fixation and inhibition of growth inhibition activity, only the protein fractions possessed activity. Thus, it appears that the major antigenic component of M. hyorhinis is a protein.
Insights
The major antigenic component of Mycoplasma hyorhinis is a protein. This protein fraction demonstrated significant complement fixation and growth inhibition activity in the study.
Area of Science:
- Veterinary Microbiology
- Immunology
- Bacteriology
Background:
- Mycoplasma hyorhinis is an important pathogen in swine, causing significant economic losses.
- Understanding the antigenic components of M. hyorhinis is crucial for developing effective vaccines and diagnostics.
- Previous studies have suggested various components contribute to the antigenicity of mycoplasmas.
Purpose of the Study:
- To identify the primary antigenic component responsible for the immune response to Mycoplasma hyorhinis.
- To determine which molecular fraction (lipid, carbohydrate, or protein) elicits the strongest immune activity.
Main Methods:
- Mycoplasma hyorhinis organisms were separated into distinct lipid, carbohydrate, and protein fractions.
- These fractions were subjected to complement fixation tests to assess antibody binding.
- Growth inhibition assays were performed to evaluate the biological activity of the fractions.
Main Results:
- Only the protein fractions of Mycoplasma hyorhinis exhibited significant complement fixation activity.
- The protein fractions were also responsible for the observed inhibition of Mycoplasma hyorhinis growth.
- Lipid and carbohydrate fractions showed minimal to no antigenic activity.
Conclusions:
- The major antigenic component of Mycoplasma hyorhinis is a protein.
- This protein is likely a key target for the host immune response and for vaccine development.
- Further characterization of this protein could lead to improved diagnostic tools and immunotherapies.